Dr. Reckamp on Molecular Testing in Lung Cancer

Karen Reckamp, MD, MS
Published: Thursday, Dec 28, 2017



Karen Reckamp, MD, MS, medical oncologist, City of Hope, discusses the role of molecular testing for patients with lung cancer.

Molecular testing is important because there are genes that have specific targeted drugs available, explains Reckamp.

According to Reckamp, moving towards next-generation sequencing is important so that there is more access for more patients but it needs to be made affordable.
 
SELECTED
LANGUAGE


Karen Reckamp, MD, MS, medical oncologist, City of Hope, discusses the role of molecular testing for patients with lung cancer.

Molecular testing is important because there are genes that have specific targeted drugs available, explains Reckamp.

According to Reckamp, moving towards next-generation sequencing is important so that there is more access for more patients but it needs to be made affordable.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Advances in™ Therapies for Patients With ALK-Positive Lung Cancers: More Options…More Decisions…Better OutcomesAug 30, 20191.5
Oncology Briefings™: Treating Advanced NSCLC Without Actionable MutationsAug 30, 20191.0
Publication Bottom Border
Border Publication
x